Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3880633010 | Product containing crizanlizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3880947012 | Crizanlizumab-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing crizanlizumab (medicinal product) | Is a | Product containing selective adhesion molecule inhibitor (product) | true | Inferred relationship | Some | ||
| Product containing crizanlizumab (medicinal product) | Is a | Product containing immunoglobulin (product) | true | Inferred relationship | Some | ||
| Product containing crizanlizumab (medicinal product) | Is a | Product containing monoclonal antibody (product) | true | Inferred relationship | Some | ||
| Product containing crizanlizumab (medicinal product) | Has active ingredient | Crizanlizumab (substance) | true | Inferred relationship | Some | 1 | |
| Product containing crizanlizumab (medicinal product) | Is a | Product containing immunomodulator (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only crizanlizumab (medicinal product) | Is a | True | Product containing crizanlizumab (medicinal product) | Inferred relationship | Some | |
| Crizanlizumab-containing product in parenteral dose form | Is a | True | Product containing crizanlizumab (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR